788 Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety and cerebrospinal fluid biomarkers

類似資料

• Proton craniospinal irradiation with bevacizumab and pembrolizumab for leptomeningeal disease: a case report
  著者:: Mason J Webb, 等
  出版事項: (2023-09-01)
• Case report: Concurrent intrathecal and intravenous pembrolizumab for metastatic melanoma with leptomeningeal disease
  著者:: Xiang Dan, 等
  出版事項: (2024-04-01)
• Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma
  著者:: Jarushka Naidoo, 等
  出版事項: (2020-10-01)
• Glucagon-Like Peptide-1 Receptor Agonists and Primary Malignant Brain Tumor Risk in Type 2 Diabetes
  著者:: Dr. Jordina Rincon-Torroella, 等
  出版事項: (2025-01-01)
• Durable complete leptomeningeal and intracerebral responses to first-line Pembrolizumab in highly-selected Non-small cell lung cancer patients
  著者:: Yi Tong Vincent Aw, 等
  出版事項: (2023-03-01)